Skip to main content

Site notifications

(Approval lapsed) ​​Prazosin hydrochloride capsules, USP 5mg (Novitium Pharma, USA)​ 

Section 19A approved medicine
(Approval lapsed) ​​Prazosin hydrochloride capsules, USP 5mg (Novitium Pharma, USA)​ 
Section 19A approval holder
ORSPEC Pharma Pty Ltd ABN ​15 634 980 417
Phone
02 4339 4239
Approved until
Status
Expired
Medicines in short supply/unavailable
APO-PRAZOSIN prazosin (as hydrochloride) 5mg tablet blister pack - ARTG 73866
Indication(s)

In Patients with Hypertension.

Prazosin is indicated in the treatment of hypertension of varied aetiology and all grades of severity. It can be used as the initial and sole agent or it may be employed in a treatment programme in conjunction with other antihypertensive agents.

Images
Picture of Prazosin Hydrochloride Capsules USP 5mg bottle - label